Total Payments
$15,130
2024 Payments
$20.95
Companies
57
Transactions
1,113
Medicare Patients
1,372
Medicare Billing
$85,231
Payment Breakdown by Category
Food & Beverage$15,130 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,130 | 1,113 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,183 | 169 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,862 | 93 | $0 (2023) |
| Novo Nordisk Inc | $1,719 | 144 | $0 (2023) |
| Lilly USA, LLC | $1,026 | 97 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $904.52 | 63 | $0 (2023) |
| AbbVie Inc. | $877.09 | 67 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $770.67 | 54 | $0 (2022) |
| Gilead Sciences, Inc. | $656.25 | 46 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $613.35 | 56 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $562.27 | 41 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.95 | 1 | Abbott Laboratories ($20.95) |
| 2023 | $1,407 | 88 | GlaxoSmithKline, LLC. ($387.30) |
| 2022 | $2,259 | 142 | GlaxoSmithKline, LLC. ($467.86) |
| 2021 | $2,558 | 166 | Novo Nordisk Inc ($313.95) |
| 2020 | $1,505 | 101 | GlaxoSmithKline, LLC. ($207.47) |
| 2019 | $2,751 | 243 | AstraZeneca Pharmaceuticals LP ($325.96) |
| 2018 | $2,212 | 174 | GlaxoSmithKline, LLC. ($412.12) |
| 2017 | $2,416 | 198 | AstraZeneca Pharmaceuticals LP ($737.65) |
All Payment Transactions
1,113 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Vascular | ||||||
| 09/26/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Gastroenterology | ||||||
| 09/01/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: RESPIRATORY | ||||||
| 08/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.06 | General |
| 08/23/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Diabetes | ||||||
| 08/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.49 | General |
| Category: NEUROLOGY | ||||||
| 08/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: VACCINES | ||||||
| 07/24/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.69 | General |
| 07/19/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.18 | General |
| 07/18/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 07/07/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: VACCINES | ||||||
| 07/07/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 372 | 437 | $47,836 | $24,991 |
| 2022 | 8 | 434 | 545 | $44,072 | $28,943 |
| 2021 | 6 | 331 | 396 | $27,274 | $18,735 |
| 2020 | 4 | 235 | 299 | $22,649 | $12,562 |
Total Patients
1,372
Total Services
1,677
Medicare Billing
$85,231
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 164 | $29,231 | $13,794 | 47.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $6,920 | $4,866 | 70.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 78 | $8,428 | $4,281 | 50.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 16 | 16 | $1,018 | $552.00 | 54.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 19 | 19 | $370.99 | $362.72 | 97.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 24 | $832.00 | $356.84 | 42.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $347.18 | $344.05 | 99.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 11 | 11 | $283.31 | $282.54 | 99.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 66 | 70 | $405.50 | $152.16 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 188 | $22,062 | $13,413 | 60.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 144 | $12,277 | $7,292 | 59.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 45 | 45 | $5,883 | $5,821 | 99.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 36 | 36 | $1,926 | $1,530 | 79.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 21 | $630.00 | $341.60 | 54.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 12 | 12 | $247.60 | $231.78 | 93.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 67 | 83 | $775.00 | $182.86 | 23.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $271.74 | $131.13 | 48.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 97 | $10,829 | $7,098 | 65.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 139 | $10,734 | $6,780 | 63.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 28 | 28 | $3,627 | $3,627 | 100.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 19 | 19 | $859.37 | $859.37 | 100.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 79 | 100 | $1,000 | $225.00 | 22.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 13 | $224.38 | $145.68 | 64.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 128 | $9,856 | $5,183 | 52.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 61 | 83 | $9,283 | $4,645 | 50.0% |
About Dr. Celia Servin, MD
Dr. Celia Servin, MD is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1326336371.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Celia Servin, MD has received a total of $15,130 in payments from pharmaceutical and medical device companies, with $20.95 received in 2024. These payments were reported across 1,113 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($15,130).
As a Medicare-enrolled provider, Servin has provided services to 1,372 Medicare beneficiaries, totaling 1,677 services with total Medicare billing of $85,231. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 07/12/2011
- Last Updated 09/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326336371
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,069
- FARXIGA (Drug) $908.98
- JARDIANCE (Drug) $904.20
- Ozempic (Drug) $632.51
- XIFAXAN (Drug) $578.39
- SHINGRIX (Biological) $461.59
- TRULICITY (Drug) $371.27
- Victoza (Drug) $354.69
- SOLIQUA 100/33 (Biological) $300.80
- Trintellix (Drug) $284.41
- TRINTELLIX (Drug) $270.82
- Kerendia (Drug) $247.44
- UBRELVY (Drug) $240.58
- BYDUREON (Drug) $231.25
- Saxenda (Drug) $230.71
- ANORO (Drug) $229.87
- Rybelsus (Drug) $227.14
- Vascepa (Drug) $224.31
- LINZESS (Drug) $220.93
- Aimovig (Biological) $219.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Family Medicine $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
Family Medicine $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Family Medicine $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Family Medicine $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Family Medicine $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768
Family Medicine $32,768